2009 Results
Young Investigator Awards
- 18F Labeled benzamides for pre-clinical PET imaging of melanoma
- Combining an MDM2 inhibitor with chemotherapy for the treatment of melanoma
- The role of oncogenic signaling pathways in human melanoma immune evasion
Established Investigator Awards
- Targeting signaling pathways for therapy in a new mouse model of melanoma
- Development of intra-tumoral prognostic biomarkers for primary melanoma
- Treatment of melanoma combining cancer gene therapy and immunotherapy
- A phase I trial of bevacizumab plus ipilimumab in melanoma patients
- Targeting the IGF1R pathway in melanoma
- Targeted strategy for treatment of melanoma
Pilot Awards
- Sulforaphane, a melanoma prevention agent for high-risk MC1R genotypes
- Mechanisms of melanoma treatment resistance
- Treatment of established melanoma by tumor-specific Th17 cells
Development Award
Science Awards
- Developing Melanoma Screening in Primary Care
- Manipulating Immune Regulation in Adoptive T-cell Therapy for Melanoma
- Identification and Validation of Combination Therapies for Melanomas
- Sequencing of the Melanoma Exome, Transcriptome and Epigenome
- ombinatorial Immunotherapy for Melanoma with B7-H1/PD-1 Checkpoint Blockade
- Identification of Novel Melanoma Risk Genes Using High-throughput Genomics
- Defining the Importance of Immunity to NY-ESO-1 in Melanoma